µþ°ù²¹¾±²Ô-´Ç²Ô-²¹-°ä³ó¾±±è.Ìý°Â³ó±ð²ÔÌý²ú°ù²¹¾±²ÔÌý³¦±ð±ô±ô²õÌý²¹°ù±ðÌý¾±²Ô³Ù°ù´Ç»å³Ü³¦±ð»åÌý´Ç²Ô³Ù´ÇÌý³Ù³ó±ðÌý³¦³ó¾±±è,Ìý³Ù³ó±ð²âÌý³¦²¹²ÔÌý³Ü²õ±ðÌý³Ù³ó±ðÌý²Ô²¹²Ô´Ç·É¾±°ù±ðÌý²¹²õÌý²õ³¦²¹´Ú´Ú´Ç±ô»å¾±²Ô²µÌý³Ù´ÇÌý²ú³Ü¾±±ô»åÌý´Ú³Ü²Ô³¦³Ù¾±´Ç²Ô²¹±ôÌý²Ô±ð³Ü°ù´Ç²Ô²¹±ôÌý³¦¾±°ù³¦³Ü¾±³Ù²õÌý³Ù³ó²¹³ÙÌý³¾¾±³¾¾±³¦Ìý³Ù³ó±ðÌý¾±²Ô³Ù±ð°ù³¦´Ç²Ô²Ô±ð³¦³Ù¾±±¹¾±³Ù²âÌý´Ç´ÚÌý²Ô±ð³Ü°ù´Ç²Ô²õÌý¾±²ÔÌý³Ù³ó±ðÌý²ú°ù²¹¾±²Ô.Ìý°¿²Ô³¦±ðÌý³Ù³ó±ðÌý±ô²¹³Ù³Ù¾±³¦±ðÌý¾±²õÌý³¦´Ç²Ô²õ³Ù°ù³Ü³¦³Ù±ð»å,Ìý°ù±ð²õ±ð²¹°ù³¦³ó±ð°ù²õÌý³¦²¹²ÔÌý²Ô´Ç³ÙÌý´Ç²Ô±ô²âÌý´Ç²ú²õ±ð°ù±¹±ðÌý³Ù³ó±ðÌý³¦´Ç²Ô²Ô±ð³¦³Ù¾±±¹¾±³Ù²âÌý²¹²õ-¾±²õÌý²ú³Ü³ÙÌý²õ³Ù³Ü»å²âÌý³Ù³ó±ðÌý¾±³¾±è²¹³¦³ÙÌý´Ç´ÚÌý»å¾±²õ±ð²¹²õ±ðÌý²¹²Ô»åÌý³Ù°ù²¹³Ü³¾²¹.
Âé¶¹Ô´´ Analysis and Insights: Global Brain-on-a-chip Âé¶¹Ô´´
The global Brain-on-a-chip market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Brain-on-a-chip is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Brain-on-a-chip is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Brain-on-a-chip is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Brain-on-a-chip include Emulate, Tissuse, Hesperos, CN Bio Innovations, Draper Laboratory, Mimetas, Nortis, Kirkstall and Cherry Biotech SAS, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Brain-on-a-chip is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Other End Users,, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Brain-on-a-chip industry development. In 2023, global % revenue of Brain-on-a-chip went into Pharmaceutical & Biotechnology Companies filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Brain-on-a-chip market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Brain-on-a-chip, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Brain-on-a-chip, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Brain-on-a-chip revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Brain-on-a-chip market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Brain-on-a-chip revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Segment by Type
Therapeutic Brain-on-a-chip
Enhanced Brain-on-a-chip
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Brain-on-a-chip in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain-on-a-chip companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain-on-a-chip revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Brain-on-a-chip Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Therapeutic Brain-on-a-chip
1.2.3 Enhanced Brain-on-a-chip
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Brain-on-a-chip Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain-on-a-chip Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global Brain-on-a-chip Growth Trends by Region
2.2.1 Brain-on-a-chip Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain-on-a-chip Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Brain-on-a-chip Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Brain-on-a-chip Âé¶¹Ô´´ Dynamics
2.3.1 Brain-on-a-chip Industry Trends
2.3.2 Brain-on-a-chip Âé¶¹Ô´´ Drivers
2.3.3 Brain-on-a-chip Âé¶¹Ô´´ Challenges
2.3.4 Brain-on-a-chip Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Brain-on-a-chip by Players
3.1.1 Global Brain-on-a-chip Revenue by Players (2019-2024)
3.1.2 Global Brain-on-a-chip Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Brain-on-a-chip Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Brain-on-a-chip, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Brain-on-a-chip Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Brain-on-a-chip Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain-on-a-chip Revenue in 2023
3.5 Global Key Players of Brain-on-a-chip Head office and Area Served
3.6 Global Key Players of Brain-on-a-chip, Product and Application
3.7 Global Key Players of Brain-on-a-chip, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain-on-a-chip Breakdown Data by Type
4.1 Global Brain-on-a-chip Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Brain-on-a-chip Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Brain-on-a-chip Breakdown Data by Application
5.1 Global Brain-on-a-chip Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Brain-on-a-chip Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Brain-on-a-chip Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Type
6.2.1 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America Brain-on-a-chip Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Application
6.3.1 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America Brain-on-a-chip Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Country
6.4.1 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America Brain-on-a-chip Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Brain-on-a-chip Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Type
7.2.1 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe Brain-on-a-chip Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Application
7.3.1 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe Brain-on-a-chip Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Country
7.4.1 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe Brain-on-a-chip Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Brain-on-a-chip Âé¶¹Ô´´ Size (2019-2030)
8.2 China Brain-on-a-chip Âé¶¹Ô´´ Size by Type
8.2.1 China Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China Brain-on-a-chip Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China Brain-on-a-chip Âé¶¹Ô´´ Size by Application
8.3.1 China Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China Brain-on-a-chip Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Brain-on-a-chip Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Type
9.2.1 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia Brain-on-a-chip Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Application
9.3.1 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia Brain-on-a-chip Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Region
9.4.1 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia Brain-on-a-chip Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Brain-on-a-chip Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Brain-on-a-chip Introduction
11.1.4 Emulate Revenue in Brain-on-a-chip Business (2019-2024)
11.1.5 Emulate Recent Developments
11.2 Tissuse
11.2.1 Tissuse Company Details
11.2.2 Tissuse Business Overview
11.2.3 Tissuse Brain-on-a-chip Introduction
11.2.4 Tissuse Revenue in Brain-on-a-chip Business (2019-2024)
11.2.5 Tissuse Recent Developments
11.3 Hesperos
11.3.1 Hesperos Company Details
11.3.2 Hesperos Business Overview
11.3.3 Hesperos Brain-on-a-chip Introduction
11.3.4 Hesperos Revenue in Brain-on-a-chip Business (2019-2024)
11.3.5 Hesperos Recent Developments
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Details
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Brain-on-a-chip Introduction
11.4.4 CN Bio Innovations Revenue in Brain-on-a-chip Business (2019-2024)
11.4.5 CN Bio Innovations Recent Developments
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Details
11.5.2 Draper Laboratory Business Overview
11.5.3 Draper Laboratory Brain-on-a-chip Introduction
11.5.4 Draper Laboratory Revenue in Brain-on-a-chip Business (2019-2024)
11.5.5 Draper Laboratory Recent Developments
11.6 Mimetas
11.6.1 Mimetas Company Details
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Brain-on-a-chip Introduction
11.6.4 Mimetas Revenue in Brain-on-a-chip Business (2019-2024)
11.6.5 Mimetas Recent Developments
11.7 Nortis
11.7.1 Nortis Company Details
11.7.2 Nortis Business Overview
11.7.3 Nortis Brain-on-a-chip Introduction
11.7.4 Nortis Revenue in Brain-on-a-chip Business (2019-2024)
11.7.5 Nortis Recent Developments
11.8 Kirkstall
11.8.1 Kirkstall Company Details
11.8.2 Kirkstall Business Overview
11.8.3 Kirkstall Brain-on-a-chip Introduction
11.8.4 Kirkstall Revenue in Brain-on-a-chip Business (2019-2024)
11.8.5 Kirkstall Recent Developments
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Details
11.9.2 Cherry Biotech SAS Business Overview
11.9.3 Cherry Biotech SAS Brain-on-a-chip Introduction
11.9.4 Cherry Biotech SAS Revenue in Brain-on-a-chip Business (2019-2024)
11.9.5 Cherry Biotech SAS Recent Developments
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Details
11.10.2 Else Else Kooi Laboratory Business Overview
11.10.3 Else Else Kooi Laboratory Brain-on-a-chip Introduction
11.10.4 Else Else Kooi Laboratory Revenue in Brain-on-a-chip Business (2019-2024)
11.10.5 Else Else Kooi Laboratory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Ìý
Ìý
*If Applicable.